Dexcom · 3 days ago
Intern II - User Research
United States
Internship
Onsite
Intern
$29/hr - $39/hr
Start in 2026 SummerDexcom Corporation is a global leader in continuous glucose monitoring, dedicated to improving human health through innovative technology. The Intern II - User Research role involves conducting user research to inform product development, collaborating with cross-functional teams, and synthesizing insights for stakeholders.
DiabetesHealth DiagnosticsMedical DeviceSensor
Responsibilities
You will conduct both primary and secondary research to uncover user behaviors, attitudes, and pain points related to our products and solutions
You will own a research project across the E2E research process from initial test plan development to final reporting and presentation
You will synthesize and communicate key insights to stakeholders through presentations and workshops
You will collaborate closely with fellow user researchers, market researchers, designers, product managers, and engineering teams to drive impactful outcomes
Qualification
Required
Requires a completed Bachelor's degree
Must be a currently enrolled Master's, JD, or PhD student at an accredited college or university with an expected graduation date of December 2026 or later
Benefits
Participation in a targeted Learning Series that encourages professional development topics and provides insight into Dexcom's culture and career opportunities.
Engagement in Social Events, Intern Recognition Awards, Paid Holidays, and more!
Company
Dexcom
Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.
Founded in 1999
10001+ employees
H1B Sponsorship
Dexcom has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (41)
2023 (67)
2022 (75)
2021 (49)
2020 (36)
Funding
Current Stage
Public CompanyTotal Funding
$2.16BKey Investors
RWI Group
2023-05-02Post Ipo Debt· $1B
2020-05-12Post Ipo Debt
2018-11-01Post Ipo Equity· $750M
Leadership Team
Jacob Leach
Chief Operating Officer
Matt Dolan
Executive Vice President, Strategy, Corporate Development & Dexcom Labs
Recent News
2026-01-13
San Diego Union-Tribune
2026-01-08
Company data provided by crunchbase